Immediate Impact
55 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Works of Adèle Coriati being referenced
Impact of a high emergency lung transplantation programme for cystic fibrosis in France: insight from a comparison with Canada
2021
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Adèle Coriati | 448 | 84 | 195 | 225 | 39 | 661 | |
| Michael S. Stalvey | 426 | 50 | 151 | 126 | 32 | 704 | |
| Tamarah Katz | 538 | 61 | 54 | 173 | 34 | 790 | |
| Daniel B. Caplan | 352 | 42 | 55 | 104 | 29 | 769 | |
| Yvonne Belessis | 477 | 43 | 42 | 139 | 28 | 586 | |
| Michael J. Coffey | 284 | 12 | 50 | 293 | 41 | 711 | |
| Oppenheimer Eh | 357 | 27 | 33 | 219 | 26 | 667 | |
| Eggert Lilienthal | 104 | 28 | 534 | 399 | 34 | 782 | |
| Takahisa Kimata | 159 | 41 | 24 | 151 | 56 | 771 | |
| Ross F. Goldberg | 142 | 38 | 89 | 302 | 25 | 602 | |
| Hume Dm | 221 | 68 | 43 | 292 | 53 | 722 |
All Works
Login with ORCID to disown or claim papers
Loading papers...